4. Reynolds LM, Consedine NS, Pizarro DA, et al. Disgust and behavioral avoidance in colorectal cancer screening and treatment: a systematic review and research agenda. Cancer Nurs 2013;36:122–130.
5. Triantafillidis JK, Vagianos C, Gikas A, et al. Screening for colorectal cancer: the role of the primary care physician. Eur J Gastroenterol Hepatol 2017;29:e1–e7.
6. Green AR, Peters-Lewis A, Percac-Lima S, et al. Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med 2008;23:834–840.
7. Hasan F, Mahmood Shah SM, Munaf M, et al. Barriers to colorectal cancer screening in Pakistan. Cureus 2017;9, e1477.
8. Honein-AbouHaidar GN, Kastner M, Vuong V, et al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2016;25:907–917.
9. Nagelhout E, Comarell K, Samadder NJ, et al. Barriers to colorectal cancer screening in a racially diverse population served by a safety-net clinic. J Community Health 2017;42:791–796.
10. Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prevent Med 2006;30:313–319.
11. Berkowitz Z, Hawkins NA, Peipins LA, et al. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc 2008;56:307–314.
12. Jones RM, Woolf SH, Cunningham TD, et al. The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med 2010;38:499–507.
13. O’Malley AS, Beaton E, Yabroff KR, et al. Patient and provider barriers to colorectal cancer screening in the primary care safety-net. Prev Med 2004;39:56–63.
14. Taylor V, Lessler D, Mertens K, et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc 2003;95:806–812.
15. Tessaro I, Mangone C, Parkar I, et al. Knowledge, barriers, and predictors of colorectal cancer screening in an Appalachian church population. Prev Chronic Dis 2006;3:A123.
16. Brawarsky P, Brooks DR, Mucci LA, et al. Effect of physician recommendation and patient adherence on rates of colorectal cancer testing. Cancer Detect Prev 2004;28:260–268.
17. Shokar NK, Carlson CA, Weller SC. Factors associated with racial/ethnic differences in colorectal cancer screening. J Am Board Fam Med 2008;21:414–426.
18. Walsh JME, Kaplan CP, Nguyen B, et al. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med 2004;19:156–166.
19. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005;41:23–29.
20. Carcaise-Edinboro P, Bradley CJ. Influence of patient-provider communication on colorectal cancer screening. Med Care 2008;46:738–745.
21. Gennarelli M, Jandorf L, Cromwell C, et al. Barriers to colorectal cancer screening: inadequate knowledge by physicians. Mt Sinai J Med NY 2005;72:36–44.
22. Şahin MK, Aker S. Family physicians’ knowledge, attitudes, and practices toward colorectal cancer screening. J Cancer Educ 2017;3:908–913.
23. Katz ML, James AS, Pignone MP, et al. Colorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communication. BMC Public Health 2004;4:62.
24. Allen JD, Leyva B, Torres MI, et al. Religious beliefs and cancer screening behaviors among Catholic Latinos: implications for faith-based interventions. J Health Care Poor Underserved 2014;25:503–526. .
25. Bechtel GA, Davidhizar RE. Integrating cultural diversity in patient education. Semin Nurse Manag 1999;7:193–197.
26. Holt CL, Litaker MS, Scarinci IC, et al. Spiritually based intervention to increase colorectal cancer screening among African Americans: screening and theory-based outcomes from a randomized trial. Health Educ Behav 2013;40:458–468.
27. Balasooriya-Smeekens C, Walter FM, Scott S. The role of emotions in time to presentation for symptoms suggestive of cancer: a systematic literature review of quantitative studies. Psychooncology 2015;24:1594–1604.
28. Consedine NS, Adjei BA, Ramirez PM, et al. An object lesson: source determines the relations that trait anxiety, prostate cancer worry, and screening fear hold with prostate screening frequency. Cancer Epidemiol Biomarkers Prev 2008;17:1631–1639.
29. Consedine NS, Magai C, Krivoshekova YS, et al. Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev 2004;13:501–510.
30. Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology 2005;14:517–534.
31. Vrinten C, McGregor LM, Heinrich M, et al. What do people fear about cancer? A systematic review and meta-synthesis of cancer fears in the general population. Psychooncology 2017;26:1070–1079.
32. Lazarus RS, Folkman S. Stress, Appraisal, and Coping, rev. ed. New York: Springer; 1984.
33. Siminoff L, Thomson M, Dumenci L. Factors associated with delayed patient appraisal of colorectal cancer symptoms. Psychooncology 2014;23:981–988.
34. Simon AE, Waller J, Robb K, et al. Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a UK population sample. Cancer Epidemiol Biomarkers Prev 2010;19:2272–2277.
35. Devoe JE, Baez A, Angier H, et al. Insurance + access not equal to health care: typology of barriers to health care access for low-income families. Ann Fam Med 2007;5:511–518.